A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndrome

A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndrome

Abstract Background Angelman syndrome (AS) is a neurodevelopmental disorder that is caused by maternal genetic deficiency of a gene that encodes E6-AP ubiquitin-protein ligase (gene symbol UBE3A) mapping to chromosome 15q11-q13. AS leads to stiff and jerky gait, excess laughter, seizures, and severe...

Full description

Bibliographic Details
Main Authors: Julia Han, Terry Jo Bichell, Stephanie Golden, Irina Anselm, Susan Waisbren, Carlos A. Bacino, Sarika U. Peters, Lynne M. Bird, Virginia Kimonis
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Angelman syndrome
Deletion
Methylation
Silencing
Methyl donors
Betaine
Online Access:http://link.springer.com/article/10.1186/s13023-019-1216-0

Internet

http://link.springer.com/article/10.1186/s13023-019-1216-0

Similar Items